Advisory Solutions Group’s Pfizer PFE Stock Holding History

Advisory Solutions Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$383K	Buy	+13,423	New	+$357K	0.08%	194

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Advisory Solutions Group's PFE Position: Q3 2026 in Review

Advisory Solutions Group opened a new position in Pfizer (PFE) in Q3 2026: 13,423 shares worth $383K. The stake represents 0.08% of the portfolio and ranks #194 among its holdings.

881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Advisory Solutions Group held 13,423 shares of Pfizer worth $383K as of Q3 2026.
Pfizer was a new Advisory Solutions Group position in Q3 2026.
Pfizer made up 0.08% of Advisory Solutions Group's portfolio in Q3 2026, its #194 holding.
881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Advisory Solutions Group's 13F filing for Q3 2026, filed 14 Oct 2026.